Celltrion Pharm Incorporated operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Celltrion Pharm Incorporated with three other
companies in this sector in South Korea:
Theragen Etex Co Limited
sales of 101.28 billion Korean Won [US$89.53 million]
Hyundai Pharmaceutical Company Limited
(120.02 billion Korean Won [US$106.10 million]
of which 86%
was Pharmaceutical), and
Dae Han New Pharm Co., Ltd.
(109.40 billion Korean Won [US$96.71 million]
Celltrion Pharm Incorporated reported sales of 104.81 billion Korean Won (US$92.65 million)
December of 2016.
increase of 40.2%
versus 2015, when the company's sales were 74.73 billion Korean Won.
Sales at Celltrion Pharm Incorporated have increased during each of the previous five years
(and since 2011, sales have increased a total of 125%).